InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+25.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Shrivastava Sanjay, 董事. Director active across 1 company, notably enVVeno Medical Corp. Cumulatively, 3 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €19k. History available since 30 June 2022. The latest transaction was disclosed on 24 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Shrivastava Sanjay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
5,400 股@ US$2.9080.4% 占其流量Common StockSEC:0001493152-24-052112:0
标准退出：2025年3月24日 (T+90)
1,000 股@ US$3.850.056% mcap100.0% 占其流量Common StockSEC:0001493152-22-018361:0
标准退出：2022年9月28日 (T+90)
388 股Common StockSEC:0001493152-21-029234:0
3 条申报中的 3 条
About Shrivastava Sanjay
Sanjay Shrivastava is a Director at enVVeno Medical Corp. He contributes to the governance of the company by participating in strategic decision-making and performance evaluation. His experience in the medical sector allows him to provide valuable insights to the management team.
